Emmaus Life Sciences, Inc. announced that it has received marketing authorization from the Oman Ministry of Health for the commercial distribution and sale of Endari® in the country to treat.
Sickle Cell Disease Treatment Commercially Available in Five GCC Countries TORRANCE, Calif., July 13, 2023 /PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX:EMMA), a leader in sickle cell disease treatment, today
Sickle Cell Disease Treatment Commercially Available in Five GCC Countries
TORRANCE, Calif., July 13, 2023 /PRNewswire/ Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment,.